Industry News
Experimental Vaccine Therapies Complicated By Cancer 'Turning Off' Important Immune Cells
Sep 03, 2012
A research report published in the September 2012 issue of the Journal of Leukocyte Biology offers a possible explanation of why some cancer vaccines are not as effective as hoped, while at the same time identifies a new therapeutic strategy for treating autoimmune problems... Read More
Experimental Vaccine Therapies Complicated By Cancer 'Turning Off' Important Immune Cells
Sep 03, 2012
A research report published in the September 2012 issue of the Journal of Leukocyte Biology offers a possible explanation of why some cancer vaccines are not as effective as hoped, while at the same time identifies a new therapeutic strategy for treating autoimmune problems... Read More
A Possible Therapy For Tamoxifen-Resistant Breast Cancer Identified
Sep 03, 2012
A study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has discovered how tamoxifen-resistant breast-cancer cells grow and proliferate. It also suggests that an experimental agent might offer a novel targeted therapy for tamoxifen-resistant breast cancer... Read More
Diverse Metabolic Roles Revealed For PML Tumor Suppressor Gene
Sep 03, 2012
Two papers led by scientific teams from the Cancer Genetics Program at Beth Israel Deaconess Medical Center (BIDMC) shed new light on the genetic mechanisms underlying cellular energy and metabolism and, at the same time, highlight both the challenges and opportunities of genetic approaches to cancer treatment... Read More
Microcirculation Of Malaria-Infected Red Blood Cells Impeded By Protein
Sep 03, 2012
When the parasite responsible for malaria infects human red blood cells, it launches a 48-hour remodeling of the host cells. During the first 24 hours of this cycle, a protein called RESA undertakes the first step of renovation: enhancing the stiffness of the cell membranes... Read More
Microcirculation Of Malaria-Infected Red Blood Cells Impeded By Protein
Sep 03, 2012
When the parasite responsible for malaria infects human red blood cells, it launches a 48-hour remodeling of the host cells. During the first 24 hours of this cycle, a protein called RESA undertakes the first step of renovation: enhancing the stiffness of the cell membranes... Read More
Quest Diagnostics Launches Molecular Cervical Cancer Test Based On National Institutes Of Health's TERC Gene Marker
Sep 01, 2012
May enhance evaluation of cancer risk in the up to 1... Read More
Mechanism Discovered That Leads From Trichomoniasis To Prostate Cancer
Sep 01, 2012
Researchers have identified a way in which men can develop prostate cancer after contracting trichomoniasis, a curable but often overlooked sexually transmitted disease. Previous studies have teased out a casual, epidemiological correlation between the two diseases, but this latest study suggests a more tangible biological mechanism... Read More
Mechanism Discovered That Leads From Trichomoniasis To Prostate Cancer
Sep 01, 2012
Researchers have identified a way in which men can develop prostate cancer after contracting trichomoniasis, a curable but often overlooked sexually transmitted disease. Previous studies have teased out a casual, epidemiological correlation between the two diseases, but this latest study suggests a more tangible biological mechanism... Read More
Quest Diagnostics Launches Molecular Cervical Cancer Test Based On National Institutes Of Health's TERC Gene Marker
Sep 01, 2012
May enhance evaluation of cancer risk in the up to 1... Read More
Previous Page Next Page